-
Something wrong with this record ?
Type 1 diabetes and LADA--occurrence of HLA-DRB1 *03 and DRB1 *04 alleles in two age different groups of diabetics
P. Weber, H. Meluzínová, H. Kubesová, P. Ambrosová, V. Polcarová, P. Cejkova, M. Cerna,
Language English Country Russia (Federation)
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21033293
Knihovny.cz E-resources
- MeSH
- Alleles MeSH
- C-Peptide blood MeSH
- Diabetes Mellitus, Type 1 diagnosis drug therapy epidemiology genetics MeSH
- Adult MeSH
- Gene Frequency MeSH
- Genetic Predisposition to Disease MeSH
- Genotype MeSH
- Glycated Hemoglobin analysis MeSH
- HLA-DR Antigens genetics MeSH
- HLA-DRB1 Chains MeSH
- Hypoglycemic Agents administration & dosage therapeutic use MeSH
- Insulin administration & dosage therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Polymerase Chain Reaction MeSH
- Predictive Value of Tests MeSH
- Risk MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Aging genetics MeSH
- Case-Control Studies MeSH
- Age of Onset MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Type 1 Diabetes Mellitus (T1D) with an onset in adulthood and Late Autoimmune Diabetes of Adults (LADA) are connected with autoimmune insulitis (associated with islet cell autoantibodies) and the specific high-risk HLA class II genotype. The study was aimed at analyzing time and clinical characteristics of the diabetics with an onset of the disease after 35 y. (T1D and LADA). Main target of the study was to assess possible role of the old age onset and compare it with diabetics with the onset in the middle age (incl. analyzing HLA-DRB1 genotype). In the study, we included 103 diabetics with an onset of autoimmune diabetes at 35+ y. who were hospitalized and afterwards long-term observed in the diabetological outpatient department. 46 men and 57 women of the average age 65.7 +/- 13.8 y. (range 35-93 y.) were out of this number. 41 were assessed as the T1D patients and 61 as the LADA ones. As a control group we used 99 healthy individuals. Patients of the T1D subgroup developed diabetes in the age of 50.8 +/- 15.1 y. and of the LADA subgroup in the age of 52.6 +/- 12.8 y. Its duration in the time of this study was 10.7 +/- 11.6 y.; respectively 5.3 +/- 7.1 y. Fasting and postprandial C-peptide levels were statistically higher (p < 0.01) in the LADA subgroup vs. T1D. Obesity 1st and 2nd grade were present together only in 12.6%. BMI was not statistically significantly different between both groups. We found in our diabetic patients the predisposition alleles HLA-DRB1*03, HLA-DRB1*04 and particularly their combination. The occurrence of these HLA alleles is significantly higher in T1D patients in comparison to control groups (p = 0.01, OR = 4.0). In our study, the occurrence of the susceptible HLA-DRB1*03 and HLA-DRB1*04 alleles in T1D patients is higher than in LADA. The presence of these alleles identifies patients of high risk and requirement of insulin therapy. Since risk alleles are similarly present in middle and old age, environmental factors probably play similar role in these onsets of autoimmune diabetes.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026080
- 003
- CZ-PrNML
- 005
- 20121206104150.0
- 007
- ta
- 008
- 120817s2010 ru f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)21033293
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ru
- 100 1_
- $a Weber, Pavel $7 xx0102175 $u Department of Internal Medicine, Geriatrics and Practical Medicine, Faculty Hospital and Masaryk University, Brno, Czech Republic. p.weber@fnbrno.cz
- 245 10
- $a Type 1 diabetes and LADA--occurrence of HLA-DRB1 *03 and DRB1 *04 alleles in two age different groups of diabetics / $c P. Weber, H. Meluzínová, H. Kubesová, P. Ambrosová, V. Polcarová, P. Cejkova, M. Cerna,
- 520 9_
- $a Type 1 Diabetes Mellitus (T1D) with an onset in adulthood and Late Autoimmune Diabetes of Adults (LADA) are connected with autoimmune insulitis (associated with islet cell autoantibodies) and the specific high-risk HLA class II genotype. The study was aimed at analyzing time and clinical characteristics of the diabetics with an onset of the disease after 35 y. (T1D and LADA). Main target of the study was to assess possible role of the old age onset and compare it with diabetics with the onset in the middle age (incl. analyzing HLA-DRB1 genotype). In the study, we included 103 diabetics with an onset of autoimmune diabetes at 35+ y. who were hospitalized and afterwards long-term observed in the diabetological outpatient department. 46 men and 57 women of the average age 65.7 +/- 13.8 y. (range 35-93 y.) were out of this number. 41 were assessed as the T1D patients and 61 as the LADA ones. As a control group we used 99 healthy individuals. Patients of the T1D subgroup developed diabetes in the age of 50.8 +/- 15.1 y. and of the LADA subgroup in the age of 52.6 +/- 12.8 y. Its duration in the time of this study was 10.7 +/- 11.6 y.; respectively 5.3 +/- 7.1 y. Fasting and postprandial C-peptide levels were statistically higher (p < 0.01) in the LADA subgroup vs. T1D. Obesity 1st and 2nd grade were present together only in 12.6%. BMI was not statistically significantly different between both groups. We found in our diabetic patients the predisposition alleles HLA-DRB1*03, HLA-DRB1*04 and particularly their combination. The occurrence of these HLA alleles is significantly higher in T1D patients in comparison to control groups (p = 0.01, OR = 4.0). In our study, the occurrence of the susceptible HLA-DRB1*03 and HLA-DRB1*04 alleles in T1D patients is higher than in LADA. The presence of these alleles identifies patients of high risk and requirement of insulin therapy. Since risk alleles are similarly present in middle and old age, environmental factors probably play similar role in these onsets of autoimmune diabetes.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a stárnutí $x genetika $7 D000375
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a C-peptid $x krev $7 D002096
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a diabetes mellitus 1. typu $x diagnóza $x farmakoterapie $x epidemiologie $x genetika $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a HLA-DR antigeny $x genetika $7 D006684
- 650 _2
- $a HLA-DRB1 řetězec $7 D059811
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x aplikace a dávkování $x terapeutické užití $7 D007004
- 650 _2
- $a inzulin $x aplikace a dávkování $x terapeutické užití $7 D007328
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a riziko $7 D012306
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Meluzínová, Hana $7 xx0062326
- 700 1_
- $a Matějovská Kubešová, Hana, $d 1957- $7 nlk20000083650
- 700 1_
- $a Ambrosová, P $7 gn_A_00005379
- 700 1_
- $a Polcarová, Vlasta $7 xx0102065
- 700 1_
- $a Čejková, P
- 700 1_
- $a Černá, M
- 773 0_
- $w MED00179769 $t Advances in gerontology = Uspekhi gerontologii / Rossiĭskai͡a akademii͡a nauk, Gerontologicheskoe obshchestvo $x 1561-9125 $g Roč. 23, č. 2 (2010), s. 243-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21033293 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121206104224 $b ABA008
- 999 __
- $a ok $b bmc $g 948122 $s 783426
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 23 $c 2 $d 243-8 $i 1561-9125 $m Advances in gerontology $n Adv Gerontol $x MED00179769
- LZP __
- $a Pubmed-20120817/10/04